Framing Therapeutic Opportunities in Tumor-Activated Gametogenic Programs

肿瘤激活配子发生计划中的治疗机会

• 批准号: 9257334
• 负责人: Angelique Wright Whitehurst
• 金额: $ 37.06万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-04-07 至 2021-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9257334
• 关键词: Adult; Aneuploidy; Antigens; Apoptotic; BIK gene; Behavior; Biological; Blood group antigen S; Bypass; Cell Death; Cell Death Signaling Process; Cell Survival; Cell physiology; Cells; ChIP-seq; Client; Clinical; Color; Coupled; DNA Damage; Development; Dissection; Environment; Equilibrium; Feedback; Gene Expression; Gene Expression Regulation; Genes; Genetic; Genomics; Goals; Growth; Human; Hypoxia; In Vitro; Investigation; Knowledge; Malignant Neoplasms; Mediating; Microtubules; Mitochondria; Molecular; Names; Neoplasm Metastasis; Neoplastic Cell Transformation; Neoplastic Processes; Normal tissue morphology; Ovary; Oxidative Phosphorylation; Oxygen; Paclitaxel; Phenotype; Placenta; Process; Production; Protein Analysis; Regulation; Research; Resistance; Rewards; Risk; Role; S Phase; Signal Pathway; Signal Transduction; Stimulus; Testing; Testis; Therapeutic; Therapeutic Intervention; Tissues; Transforming Growth Factor beta; Treatment Protocols; Tumor Suppressor Proteins; Tumorigenicity; Zinc Fingers; base; cancer cell; cancer testis antigen; cancer therapy; cell behavior; cell growth; chemotherapeutic agent; cohort; design; deviant; fetal; functional group; gene product; in vivo; insight; loss of function; molecular targeted therapies; neoplastic; neoplastic cell; next generation; novel; overexpression; prevent; programs; public health relevance; response; screening; self-renewal; tumor; tumor DNA; tumor initiation; tumor microenvironment; tumor progression; tumorigenesis; tumorigenic; validation studies; whole genome

 DESCRIPTION (provided by applicant): Tumors frequently re-activate genes whose expression is otherwise restricted to gametogenic tissues including the ovary, placenta and testes. Tumorigenic expression of these genes, known collectively as cancer-testes antigens (CTAs), has been documented for over 25 years; however functional knowledge of the contribution of these gene products to tumorigenesis remains scant. To examine the roles of CTAs in tumorigenic phenotypes, we have deployed a multidimensional quantitative discovery platform to examine the contribution of 120 CT antigens to neoplastic phenotypes and signaling cascades in 11 diverse tumorigenic settings. Using this screening platform, we have identified CT-antigens that are essential to many of the hallmarks of cancer including: 1) thwarting cell death signaling 2) enhanced energy production 3) hijacking developmental programs that promote self-renewal and metastases 4) adaption to low oxygen conditions inherent in the tumor microenvironment and 5) tolerance of DNA damage and aneuploidy. Thus, the objective of this proposal is to elaborate the contribution of cancer-testes antigens to neoplastic processes. The in-depth examination of the role of these CTA's in tumorigenic processes will provide conceptual breakthroughs with respect to the tumor cell regulatory environment as well as important new insights into tumor cell specific targets that could be exploited for therapeutic intervention.

 描述（由申请人提供）：肿瘤经常重新激活基因，否则这些基因的表达仅限于配子发生组织，包括卵巢、胎盘和睾丸。这些基因（统称为癌症睾丸抗原（CTA））的致瘤性表达已被记录超过25年;然而，关于这些基因产物对肿瘤发生的贡献的功能知识仍然很少。为了研究CTA在肿瘤发生表型中的作用，我们部署了一个多维定量发现平台，以研究120种CT抗原对11种不同肿瘤发生环境中肿瘤表型和信号级联的贡献。使用该筛选平台，我们已经鉴定了对许多癌症特征至关重要的CT抗原，包括：1）阻碍细胞死亡信号传导2）增强的能量产生3）劫持促进自我更新和转移的发育程序4）适应肿瘤微环境中固有的低氧条件和5）耐受DNA损伤和非整倍性。因此，本建议的目的是阐述癌-睾丸抗原对肿瘤过程的贡献。这些CTA在肿瘤发生过程中的作用的深入研究将提供关于肿瘤细胞调控环境的概念突破，以及对可用于治疗干预的肿瘤细胞特异性靶点的重要新见解。